6-(15-hydroxy-4,4,10,13,14-pentamethyl-3,7,11-trioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid

Catalog No. :
ACHHKB221
CAS No. :
100440-26-4
Molecular Formula :
C30H42O7
Molecular Weight :
514.66

IUPAC Name:6-(15-hydroxy-4,4,10,13,14-pentamethyl-3,7,11-trioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid

6-(15-hydroxy-4,4,10,13,14-pentamethyl-3,7,11-trioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-(15-hydroxy-4,4,10,13,14-pentamethyl-3,7,11-trioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid
IUPAC Name6-(15-hydroxy-4,4,10,13,14-pentamethyl-3,7,11-trioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid
Molecular FormulaC30H42O7
Molecular Weight514.66
SMILESCC(CC(=O)CC(C)C1CC(O)C2(C)C3=C(C(=O)CC12C)C1(C)CCC(=O)C(C)(C)C1CC3=O)C(=O)O
InChI KeyKIJCKCLHIXLFEW-UHFFFAOYSA-N
SynonymLanost-8-en-26-oic acid, 15-hydroxy-3,7,11,23-tetraoxo-, (15α)-;Ganoderic acid J
CAS No.100440-26-4

Synthetic Route by SureRoute

1. ACHHKB221 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHHKB221 route product structure diagram
    ACHHKB221100440-26-4
Inquiry

2. ACHHKB221 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHHKB221 route product structure diagram
    ACHHKB221100440-26-4
Inquiry

Comments (0)